Pulmonary sequestration is a developmental abnormality of the lung in which a portion of the lung tissue is functional but lacks the normal anatomical or physiological connection to a main bronchus or trachea. This condition results in the sequestered lung tissue receiving its oxygen and blood supply from the systemic circulation rather than the pulmonary vessels, which can cause numerous complications and diagnostic difficulties. Sequestered areas of lung may be either complete or partial, and typically cause prolonged and sometimes severe respiratory symptoms such as chronic cough, shortness of breath, and a predisposition to respiratory infections.
History of the disease and interesting historical facts
The discovery of pulmonary sequestration can be traced back to the late 19th century, when physicians began systematically investigating abnormalities of lung tissue. In 1884, surgeon Herff described the first case of pulmonary sequestration, which was a significant step in understanding the pathology. Throughout the 20th century, attention to the disease increased as diagnostics and treatment improved, especially with the development of radiology and CT scanning. In the 1970s, sequestration began to be recognized as an important cause of chronic lung disease, especially in children, leading to increased research and publication in medical journals. Interestingly, sequestration is more common in men, which is also the subject of medical research on gender differences in susceptibility to lung disease.
Epidemiology
According to current data, pulmonary sequestration occurs with a frequency of approximately 0.15-1% among all cases of respiratory diseases, mainly in children aged 1 to 10 years. The pathology is much less frequently diagnosed in adults. Studies show that differences in the incidence may depend on geographical location, as some areas with high air pollution have a higher rate of pulmonary sequestration. The final decision on the diagnosis is often made after long-term observation, which emphasizes the importance of raising awareness of this disease among general practitioners.
Genetic predisposition to this disease
To date, the genetic factors that contribute to the development of pulmonary sequestration remain poorly understood. However, some researchers suggest that mutations in genes responsible for lung development may play an important role in the development of anomalies. Among the genes involved are FGFR2 and GATA6, which are important for the morphogenesis of lung tissue. In addition, there is a possibility of a hereditary component, but additional studies are needed to confirm the relationship between specific genetic factors and the development of pulmonary sequestration.
Risk factors for the development of this disease
Risk factors for pulmonary sequestration include both physical and chemical factors. These include:
- History of smoking or exposure to second-hand smoke.
- Exposure to toxic chemicals such as asbestos or persistent organic pollutants.
- Presence of chronic respiratory infections in childhood.
- Genetic predisposition.
In addition to these factors, one should take into account the patient's history of various respiratory diseases, including bronchial asthma and cystic fibrosis, which can also contribute to the development of pulmonary sequestration.
Diagnosis of this disease
Diagnosis of pulmonary sequestration includes several different stages, starting with a clinical examination and ending with instrumental methods:
- The main symptoms are chronic cough, difficulty breathing, and frequent respiratory infections.
- Laboratory tests: complete blood count, biochemistry, and tests for infectious agents.
- Radiological examinations: chest X-ray, computed tomography (CT) scan for a more accurate assessment of the condition of the lung tissue.
- Other diagnostic tests include bronchoscopy to visualize the airways and check for infections or tumors.
- Differential diagnosis: It is important to exclude diseases such as lung cancer, tuberculosis and other lung abnormalities.
Treatment
Treatment of pulmonary sequestration depends on the severity of symptoms and the functional state of the lung. There are several approaches to therapy:
- General treatment: includes correction of respiratory function and treatment of concomitant diseases.
- Pharmacological treatment: antibiotics to treat respiratory infections, bronchodilators to improve airway patency.
- Surgical treatment: If the sequestration is large, a lobectomy or sequestrectomy may be needed to remove the abnormal tissue.
- Other treatments include physical therapy and breathing exercises to improve breathing function and reduce symptoms.
List of medications used to treat this disease
The main drugs used in the treatment of pulmonary sequestration include:
- Antibiotics: amoxicillin, azithromycin to fight infections.
- Bronchodilators: salbutamol, formaterol to dilate the bronchi.
- Corticosteroids: prednisolone to reduce inflammation.
Disease monitoring
Monitoring of pulmonary sequestration includes regular examinations:
- Control stages: periodic X-ray examinations to assess the condition of the lung.
- Prognosis: In most cases, with adequate diagnosis and treatment, the prognosis is relatively favorable.
- Complications: possible recurrence of infections, respiratory failure and even the risk of developing pulmonary fibrosis if timely assistance is not provided.
Age-related features of the disease
Pulmonary sequestration can present differently depending on the patient's age:
- In children: acute respiratory infections and cough are more common and may be misdiagnosed as other illnesses.
- In adults: symptoms may be less severe, but there may be more significant breathing problems.
- In older adults: Age-related changes can worsen existing lung conditions, increasing the risk of complications.
Questions and Answers
- What is pulmonary sequestration? Pulmonary sequestration is an anomaly in which a portion of the lung tissue is not connected to the main bronchus and receives blood from the systemic circulation.
- What are the main symptoms of pulmonary sequestration? The main symptoms include chronic cough, shortness of breath and frequent respiratory infections.
- How is pulmonary sequestration diagnosed? Diagnosis includes clinical examination, radiography, CT and bronchoscopy.
- What does treatment for pulmonary sequestration involve? Treatment may include medication, physical therapy, and in some cases surgery.
- What is the prognosis for pulmonary sequestration? With timely diagnosis and proper treatment, the prognosis is often favorable.
